| Menarini Forms Antibody-Based Drug Alliance with Oxford BioTherapeutics |
Abstract
|
|
Heather Cartwright |
|
| Ensemble Therapeutics Collaborates with Boehringer Ingelheim on Macrocyclic Drug Discovery |
Abstract
|
|
Heather Cartwright |
|
| Vertex Partners with GSK and Janssen on Phase II Studies of All-Oral HCV Treatment Regimens |
Abstract
|
|
Heather Cartwright |
|
| Ardelyx Licenses NHE3 Inhibitor Programme to AstraZeneca in its First Major Deal |
Abstract
|
|
Heather Cartwright |
|
| Bayer Spin-Off AiCuris Licenses Phase III-Ready Antiviral to Merck & Co. |
Abstract
|
|
Heather Cartwright |
|
| Alnylam Partners with Sanofi’s Genzyme to Advance its ALN-TTR Programme in Asia-Pacific |
Abstract
|
|
Heather Cartwright |
|
| Ironwood Pharmaceuticals Chooses AstraZeneca as Chinese Partner for Linaclotide |
Abstract
|
|
Heather Cartwright |
|
| Cinven Makes Second Speciality Pharma Acquisition of 2012 |
Abstract
|
|
Heather Cartwright |
|
| BioCryst and Presidio Merge to Compete in Oral Hepatitis C Drug Development |
Abstract
|
|
Heather Cartwright |
|
| Pfizer Forays into ADHD Market by Exercising Option to Acquire NextWave Pharmaceuticals |
Abstract
|
|
Heather Cartwright |
|
| Takeda Bolsters its CNS Pipeline with Envoy Therapeutics Purchase |
Abstract
|
|
Heather Cartwright |
|
| India’s Sun Pharma Targets US Dermatology Market with Dusa Pharmaceuticals Acquisition |
Abstract
|
|
Heather Cartwright |
|
| Pernix Therapeutics Expands Generic and Branded Product Portfolios with Cypress Pharmaceutical Acquisition |
Abstract
|
|
Heather Cartwright |
|
| Allergan Boosts Facial Aesthetics Business with SkinMedica Purchase |
Abstract
|
|
Heather Cartwright |
|
